{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Paramount",
      "address_1": "16101 Garfield Ave",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found MaXtremeZEN which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine.  Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug.  Dapoxetine is an active ingredient not approved",
      "address_2": "",
      "product_quantity": "2,395 blister packs total for all products",
      "code_info": "Lot #: JBP-L-1270-70, Exp 12/16",
      "center_classification_date": "20140130",
      "distribution_pattern": "CA",
      "state": "CA",
      "product_description": "MaXtremeZEN capsules, 1 capsule per blister pack, Distributed by: P&A Enterprise, Buena Park, CA  90621, UPC 6 10079 52468 2.",
      "report_date": "20140205",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "SS Wholesale Inc. dba Jobbers Wholesale",
      "recall_number": "D-1046-2014",
      "initial_firm_notification": "Press Release",
      "product_type": "Drugs",
      "event_id": "66840",
      "termination_date": "20140509",
      "more_code_info": "",
      "recall_initiation_date": "20131118",
      "postal_code": "90723",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}